Concepedia

Mia Svensson

MS

Statistics

Publications

4

Citations

213

H-Index

4

Active since

2003

Affiliations

AstraZeneca (United States)(Current)

Barmherzige Schwestern Krankenhaus Wien

AstraZeneca (Sweden)

University of Vienna

Mia Svensson is an author at AstraZeneca (United States) specializing in anticoagulant therapy, medicine, and direct thrombin inhibitors.

Publications per year

2003–2004

4

Publications

4

Effect of recombinant factor VIIa on melagatran-induced inhibition of thrombin generation and platelet activation in healthy volunteers

Marcel Levi, Troy C. Sarich, Stig Boström et al. · Thrombosis and Haemostasis · 2004 · 94 citations

Medicine, Hematology, Pharmacology +17

No Influence of Obesity on the Pharmacokinetics and Pharmacodynamics of Melagatran, the Active Form of the Oral Direct Thrombin Inhibitor Ximelagatran

Troy C. Sarich, Renli Teng, Gary Peters et al. · Clinical Pharmacokinetics · 2003 · 61 citations

Medicine, Pharmacokinetics, Pharmacology +13

Consistent pharmacokinetics of the oral direct thrombin inhibitor ximelagatran in patients with nonvalvular atrial fibrillation and in healthy subjects

Michael Wolzt, Maria Wollbratt, Mia Svensson et al. · European Journal of Clinical Pharmacology · 2003 · 40 citations

Medicine, Pharmacokinetics, Pharmacology +12

Effects of the Oral Direct Thrombin Inhibitor Ximelagatran on P-Selectin Expression and Thrombin Generation in Atrial Fibrillation

Michael Wolzt, Stig Boström, Mia Svensson et al. · Pathophysiology of Haemostasis and Thrombosis · 2003 · 18 citations · Full text

Medicine, Cardiology, Pharmacology +17

1–4 of 4